Navigation Links
Hepatitis in Medical News

Surveyed Physicians Will Treat Over 50 Percent of Hepatitis C Genotype 1-Infected Patients With the Protease Inhibitor Telaprevir

WALTHAM, Mass., Aug. 4 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, based on profiles provided to them of emerging protease inhibitors, surveyed physicians indicate that they will prescr...

Top Hepatitis C Treatments Equally Effective

Landmark assessment also finds treating early helps prevent liver failure WEDNESDAY, July 22 (HealthDay News) -- A landmark hepatitis C virus study shows that the top two treatment options are equally effective and safe. The long-awaited study, thought to be the largest of its kind...

Mass. General-based research center will investigate why immune system fails to control hepatitis C

A research consortium based at Massachusetts General Hospital (MGH) has been awarded $15 million from the National Institute of Allergy and Infectious Diseases to investigate how the hepatitis C virus (HCV) resists suppression and clearance by the immune system. The five-year grant will support a...

New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report

NEW YORK, July 7 /PRNewswire/ -- Reportlinker.com just added a new market research report to its catalogue. World Hepatitis C Virus And Therapeutics Market http://www.reportlinker.com/p0119497/World-Hepatitis-C-Virus-And-Therapeutics-Market.html?utm_source=PRNWire&utm_medium=...

Pharmasset Nominates PSI-938 as a New Nucleotide Analog Inhibitor of Hepatitis C for Preclinical Development

PRINCETON, N.J., July 7 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS ) announced today the nomination of PSI-352938 ("PSI-938") as a lead development candidate from two series of purine analogs for the treatment of chronic hepatitis C virus (HCV) infection. PSI-938 is a proprietary n...

JNCI news brief: Hepatitis B virus mutations may predict risk of liver cancer

Certain mutations in the DNA of the hepatitis B virus (HBV) are associated with the development of liver cancer and may help predict which patients with HBV infections are at increased risk of the disease, according to a large meta-analysis in the Journal of the National Cancer Institute , publis...

More>>

Hepatitis in Medical Technology

Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C

PRINCETON, N.J., July 31 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS ) reported today positive preliminary results from its phase I clinical trial of PSI-7851 for the treatment of hepatitis C (HCV). PSI-7851 is a second generation nucleotide polymerase inhib...

Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)

CAMBRIDGE, Mass., July 20 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that it has successfully completed a three-day...

Clinical Update - Debio 025 in Hepatitis C

LAUSANNE, Switzerland, April 28 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions, particularly in the field of oncology, presented results from a phase IIa study with Debio 025, a selective cyclophilin (...

Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting

Final results from three large PEGINTRON(TM) clinical studies address key questions in the treatment of hepatitis C COPENHAGEN, Denmark, April 27 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) today reported that final results of three large PEGINTRON(TM) (peginterferon ...

Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen

- Combination of R7227, protease inhibitor, and R7128, nucleoside polymerase inhibitor, shows significant potency in reducing viral load in patients with hepatitis C - NUTLEY, N.J., BRISBANE, Calif., and PRINCETON, N.J., April 25 /PRNewswire-FirstCall/ -- Roche, InterMune, Inc. (Nasdaq: IT...

Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C

- With half as many injections, in two pivotal Phase 3 trials, Albuferon (albinterferon alfa-2b) met the primary efficacy endpoint of sustained virologic response comparable to Pegasys (peginterferon alfa-2a) - - Patients receiving 900-mcg Albuferon had comparable rates of serious and...

More>>

Hepatitis in Medical Products

Hepatitis C Virus Quantitative with Reflex to Hepatitis C Genotype

Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...
Company:ARUP Laboratories

Autoimmune Hepatitis Panelwith Reflex to ANA IFA Titer

Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...
Company:ARUP Laboratories

Autoimmune Hepatitis Panel Pluswith Reflex to Titers

Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...
Company:ARUP Laboratories

NOW® Hepatitis B Test

Description: The NOW Hepatitis B test is a rapid field or laboratory test for the differential diagnosis of a Hepatitis B infection. This simple, two-step test provides results in 10 minutes, allowing for accurate treatment and improved patient outcomes. Intended use: The NOW® Hepatitis B sAg/eAg tes...
Company:Binax, Inc.

Determine HBsAg - Whole blood (includes chase buffer)

Description:... For the qualitative detection of hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
Company:Inverness Medical Professional Diagnostics

Determine HBsAg - Serum & Blood

Description:... For the qualitative detection of hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
Company:Inverness Medical Professional Diagnostics

More>>

Hepatitis in Medical Definition

Pathology

...s Hernia Inguinal - Femoral - Umbilical - Incisional - Diaphragmatic Liver Alcoholic liver disease - Cholestasis - hepatitis - Liver failure - Cirrhosis - NASH - PBC - Budd-Chiari - Hepatocellular carcinoma Accessory digestive Gallbladder / Biliary tree...

Réseau Sentinelles

... since 2004, Male urethritis since 1984 and hepatitis A Virus ( HAV ), hepatitis B Virus ( HBV ) and hepatitis C Virus ( HCV ) since 2000 as well as 3 non ...

Unsolved problems in medicine

...ndamental cure for all cancers? HIV / AIDS . Can we develop a vaccine or cure that wipes out all strains of HIV? Where did HIV originate? hepatitis / Herpes . And other incurable pathogenic diseases and conditions. We can treat them but how can we eliminate them? Hereditary diseases . Can gene...
Hepatitis in Medical Dictionary

Hepatitis

Comprehensive collection of resources on the five hepatitis viruses (A, B, C, D, and E) that cause liver disease. ... of fact sheets for the public and the health professionals about hepatitis A which affects the liver, occurring in situations ranging from isolated cases ... Features ...

Viral hepatitis

Viral hepatitis is liver inflammation due to a viral infection. It may present in acute or chronic forms. The most common causes of viral hepatitis are the five unrelated hepatotropic viruses Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D, and Hepatitis E. In... ...

Drug-induced hepatitis

3.3 Alcoholic hepatitis . 3.4 Drug induced . 3.5 Other toxins. 3.6 Metabolic disorders ... of drug - induced hepatitis is quite variable, depending on the drug and the ... Definition: Drug - induced hepatitis involves inflammation of the liver caused by medicati...

Autoimmune hepatitis

Anomalous presentation of human leukocyte antigen (HLA) class II on the surface of hepatocytes, possibly due to genetic predisposition or acute liver infection; causes a cell-mediated immune response against the body's own liver, resulting in autoimmune hepatitis . Although auto...

Viral Infections

...nto wounds and cause an infection . Get the details in this article for teens. ... Infections >Bacterial & Viral Infections > ... hepatitis is most commonly caused by one of three viruses. ... KidsHealth>Parents> Infections >Bacterial & Viral Infections >Hepatitis. Prin...

Viral

...h flu. From the U.S. ... Home Page of Viral hepatitis ... Adult Viral hepatitis Prevention Coordinators. Perinatal hepatitis B Prevention Coordinators ... Overview of hepa...

More>>

Hepatitis in Biological News

The hepatitis healing power of blueberry leaves

A chemical found in blueberry leaves has shown a strong effect in blocking the replication of the Hepatitis C virus, opening up a new avenue for treating chronic HCV infections, which affect 200 million people worldwide and can eventually lead to cirrhosis and liver cancer. Among the areas of ...

First human gets new antibody aimed at hepatitis C virus

Boston, Mass. Building upon a series of successful preclinical studies, researchers at MassBiologics of the University of Massachusetts Medical School (UMMS) today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody they developed ...

Novel antibody prevents infection by hepatitis C virus

Boston, Mass. Taking aim at a leading cause of liver failure in the United States, a team of scientists at the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) has developed a human monoclonal antibody that neutralizes the Hepatitis C virus (HCV...

Biolex presents Locteron US Phase 2a hepatitis C data at EASL

Biolex Therapeutics, Inc. announced that the results from its United States Phase 2a clinical trial (the "PLUS" trial) of Locteron will be presented today at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL) in Copenhagen, Denmark. Locteron, controlled-release i...

When acute hepatitis develops into chronic hepatitis

To achieve this, Carlos A. Guzmn, Head of the "Vaccinology and Applied Microbiology" working group and Robert Geffers, Head of the "Gene Expression Analysis" platform, examined the incidence and species of special defence cells, T helper cells, along with their role in the development of the disea...

Discovery could lead to a new animal model for hepatitis C

During its career, the potentially fatal hepatitis C virus has banked its success on a rather unusual strategy: its limitations. Its inability to infect animals other than humans and chimpanzees has severely hampered scientists in developing a useful small animal model for the disease. But now, in...

More>>

Hepatitis in Biological Technology

Eiger BioPharmaceuticals Acquires Exclusive License to Novel Hepatitis C Virus (HCV) Technology From Stanford University

PALO ALTO, Calif., August 4, 2009 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today that it has licensed the exclusive worldwide rights to novel Hepatitis C Virus (HCV) technology from Stanford University. This te...

Three Rivers Announces Positive Results from Phase 3 DIRECT Trial of Once-Daily INFERGEN(R) with Ribavirin in Hepatitis C Virus Treatment Failures

WARRENDALE, Pa., June 16 /PRNewswire/ -- Three Rivers Pharmaceuticals announced today positive results of the U.S.-based, randomized Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy (DIRECT) clinical trial authored by Bruce R. Bacon, M.D., of Saint Louis University , an...

Study Finds Noninvasive Blood Test for Liver Fibrosis May Alleviate Need for Liver Biopsies for Some Patients with Chronic Hepatitis C

MADISON, N.J., June 8 /PRNewswire-FirstCall/ -- A study in the June issue of Clinical Gastroenterology and Hepatology , published by Elsevier, demonstrates that the Hepascore(TM) liver fibrosis blood-serum test panel may help physicians more accurately diagnose and stage liver fibrosis in patie...

Idenix Pharmaceuticals Reports Data From Three Hepatitis C Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver

CAMBRIDGE, Mass., April 23 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today reported data from its three hepatitis C development programs being pr...

Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference

CAMBRIDGE, Mass., April 3 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ) announced today that management will present an overview of the company's three hepatitis C programs at the Canaccord Adams Hepatitis C Conference on Tuesday, April 7 at 9:45 a.m. ET at the InterCont...

InterMune to Present at Canaccord Adams Hepatitis C Conference

BRISBANE, Calif., April 3 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that Steven B. Porter, M.D., Ph.D., Chief Medical Officer of InterMune, will present at the Canaccord Adams Hepatitis C Conference on April 7, 2009 at 11:15 a.m. EDT. To access a live audio...
Hepatitis in Biological Products

ELISA Kit for Hepatitis B Surface Antigen Using GoldMag-AS Microparticles from BioChain

Description: The ELISA Kit for Hepatitis B Surface Antigen (HBsAg) is an in vitro enzyme immunoassay for the detection of HBsAg in human serum or plasma....
Company:BioChain

Normal Pooled Human Serum from Innovative Research

Description:...n (s) (HIV-1Ag), Antibodies to Human Immunodeficiency Virus (Anti-HIV 1/2), hepatitis C Virus (HCV), and Nonreactive for hepatitis B Surface Antigen (HbsAg) and Non-reactive by a screening test for syphilis...
Company:Innovative Research

Normal Human Serum-Single Donor from Innovative Research

Description:...n (s) (HIV-1Ag), Antibodies to Human Immunodeficiency Virus (Anti-HIV 1/2), hepatitis C Virus (HCV), and Nonreactive for hepatitis B Surface Antigen (HbsAg) and Non-reactive by a screening test for syphilis...
Company:Innovative Research
Hepatitis in Biological Definition

Blood

...nfection. AIDS , the virus of which, HIV , is transmitted through contact between blood, semen , or the bodily secretions of an infected person. hepatitis B and C are transmitted primarily through blood contact. Owing to blood-borne infections, bloodstained objects are treated as a biohazard . Inf...

Flaviviridae

...wing genera: Genus Flavivirus (type species Yellow fever virus , others include West Nile virus ) Genus Hepacivirus (type species hepatitis C virus ) Genus Pestivirus (type species Bovine viral diarrhea virus , others include classical swine fever or hog cholera) The genome ...

Hepadnaviridae

...e two genera included here: Genus Orthohepadnavirus ; type species: hepatitis B virus Genus Avihepadnavirus ; type species: Duck hepatitis B virus Hepadnaviruses have very small genomes of circular, partia...

Hepatitis B

... Originally known as serum hepatitis, hepatitis B has only been recognized as such since World W...rrent epidemics in parts of Asia and Africa . hepatitis B is recognized as endemic in China and various ...d's population has been or is actively infected by hepatitis B. ...

Liver

...from the blood and excretes it through bile. hepatitis , inflammation of the liver, caused mainly by vari...r diseases leading to cirrhosis , such as chronic hepatitis C, alcoholism, autoimmune hepatitis, and many othe... Melissa Palmer. Dr. Melissa Palmer's Guide to hepatitis and Liver Disease: What You Need to Know , Avery ...

RNA virus

...terial passes through an RNA intermediate during replication. For example, hepatitis B virus is classified as an RNA virus, even though its genome is double-st...es: Arenaviridae Bunyaviridae Flaviviridae : Yellow fever - hepatitis C&G Orthomyxoviridae : Influenza Paramyxoviridae : Mumps ...
Hepatitis in Biological Dictionary

Untranslated region

... terminal 3' stem-loop domain. Control of translation by ... ... of the 5' Untranslated Region Cannot Accurately Distinguish Genotypes ... of hepatitis C Virus with Reference to C/E1 and 5' Untranslated Region Sequences. ... ... loop in the coronavirus 5' untranslated region plays a functio...

Thymus gland

...ymus gland phlegm stagnation is a primary causative factor for allergies. ... NatCell Thymus and thymus gland extracts use in treatment of hepatitis C. ... Much of the healthy thymus gland structure typically atrophies by age 20, and ... In humans, the thymus is a soft, flattened, pinkish-...

Satellite RNA

...BBSV satellite RNA . ... Barley yellow dwarf virus satellite RNA : Helper - Luteovirus ... It is like a satellite RNA since it requires hepatitis virus for transmission ... The satellite RNA of bamboo mosaic virus (satBaMV) has a single open reading ... Translation of the satellite ...

RNA virus

...sh ... RNA (redirected from RNA viruses ) Also found in: Medical, Encyclopedia, Wikipedia, Hutchinson ... ... viruses , which include HIV and hepatitis B, copy their RNA into ... Double-stranded RNA viruses -- which include the rotavirus that kills about one ... RNA viruses : constant anno...

Replicon

...oftware used in productivity and expense management applications. Its... hepatitis C Virus Rna Replicon Model: Soon after the discovery of the hepatitis C virus, attention turned to the development of models whereby replication...

Recombinant

... of recombinant biotechnology. ... Recombinant Human Insulin. Diabetes. hepatitis B Vaccine. hepatitis B ... The RWJMS Recombinant DNA form should be completed and submitted...
Other Tags
(Date:7/31/2014)... NY (PRWEB) July 31, 2014 ... H2 2014, provides an overview of the Brain ... information on the therapeutic development for Brain Cancer, ... assessment by drug target, mechanism of action (MoA), ... with latest updates, and featured news and press ...
(Date:7/31/2014)... July 31, 2014 Much of the liver,s metabolic ... body clock and UC Irvine researchers have now ... The study, published online today in Cell , ... metabolism and points the way to more focused drug ... obesity and diabetes. , Paolo Sassone-Corsi, UCI,s Donald Bren ...
(Date:7/31/2014)... The virus that causes cold sores -- herpes simplex type ... according to a new study. Researchers in Australia ... infected with the virus. This explains why some people with ... them only occasionally. The authors said the findings could lead ... when the disease was dormant, it was a truce. It ...
(Date:7/31/2014)... 31, 2014 i2i Systems announced today ... Inc. (SAS) to provide a robust patient referral ... SAS is one of the largest independent software companies ... than 40,000 patients are seen annually in its on-site ... delivering primary care, providers at the SAS HCC refer ...
(Date:7/31/2014)... Over the past five years, the ... the estimated 151 million individuals that have required some ... of Ophthalmology (AAO). According to a Consumer Reports National ... vision correction surgery, a large share of consumers have ... medical procedure was to eliminate the use of glasses ...
Breaking Medicine News(10 mins):Health News:Global Brain Cancer Market Size, Share, Analysis, Trends and Forecasts 2014 2Health News:Global Brain Cancer Market Size, Share, Analysis, Trends and Forecasts 2014 3Health News:Global Brain Cancer Market Size, Share, Analysis, Trends and Forecasts 2014 4Health News:Strict genomic partitioning by biological clock separates key metabolic functions 2Health News:Cold Sore Virus Active Without Symptoms, Study Finds 2Health News:SAS Selects i2i Systems for Health Care Center Patient Referral Database 2Health News:SAS Selects i2i Systems for Health Care Center Patient Referral Database 3Health News:Eye Surgery Clinics in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Eye Surgery Clinics in the US Industry Market Research Report from IBISWorld Has Been Updated 3
(Date:7/30/2014)... researchers from the University of Helsinki and the Universitat ... in mice morphological changes which have taken millions of ... the embryonic development of mice teeth, induced in the ... similar to those observed in the fossil registry of ... ago. , To modify the development of their ...
(Date:7/30/2014)... University associate professor Andrew S. Mount, performed cutting-edge research ... for novel anti-fouling paint for ships and boats and ... The team,s findings, published in Nature Communications ... that attaches to a wide variety of surfaces using ... an underwater heavy-duty adhesive. , "In previous research, we ...
(Date:7/30/2014)... Limited today announced an across-the-board increase in Impact ... 2013 InCites Journal Citation Reports (Thomson Reuters, 2014) ... Journal , Essays in Biochemistry , ... all received increases in their Impact Factors. ... and published by Portland Press Limited. , 2014 ...
Breaking Biology News(10 mins):Scientists reproduce evolutionary changes by manipulating embryonic development of mice 2Study: Marine pest provides advances in maritime anti-fouling and biomedicine 2Across-the-board Impact Factor increases for Portland Press Limited 2
Other Contents